ranitidine has been researched along with Acute Confusional Senile Dementia in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Alzheimer's disease is a progressive brain disorder with characteristic symptoms and several pathological hallmarks." | 1.62 | 2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease. ( Andrys, R; Capek, J; Handl, J; Hrabinova, M; Janockova, J; Kobrlova, T; Korabecny, J; Marco-Contelles, JL; Mezeiova, E; Micankova, P; Muckova, L; Nepovimova, E; Pejchal, J; Rousar, T; Simunkova, M; Soukup, O; Valko, M, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Mezeiova, E | 1 |
Janockova, J | 1 |
Andrys, R | 1 |
Soukup, O | 1 |
Kobrlova, T | 1 |
Muckova, L | 1 |
Pejchal, J | 1 |
Simunkova, M | 1 |
Handl, J | 1 |
Micankova, P | 1 |
Capek, J | 1 |
Rousar, T | 1 |
Hrabinova, M | 1 |
Nepovimova, E | 1 |
Marco-Contelles, JL | 1 |
Valko, M | 1 |
Korabecny, J | 1 |
1 other study available for ranitidine and Acute Confusional Senile Dementia
Article | Year |
---|---|
2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Drug Design; Humans; Naphthoquinones; Structure-Activity Relationship | 2021 |